116 related articles for article (PubMed ID: 8435430)
21. Isolation and structural determination of a novel TRH-like tripeptide, pyroGlu-Tyr-Pro amide, from alfalfa.
Lackey DB
J Biol Chem; 1992 Sep; 267(25):17508-11. PubMed ID: 1517203
[TBL] [Abstract][Full Text] [Related]
22. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
Mizutani Y; Bonavida B; Nio Y; Yoshida O
Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activity.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1987 Sep; 108(2):313-22. PubMed ID: 3113742
[TBL] [Abstract][Full Text] [Related]
24. Reduction by OK-432 of the monolayer contact-mediated inhibition of human natural killer cell activity.
Yagita M; Saksela E
Immunol Lett; 1990 Sep; 25(4):347-53. PubMed ID: 2249878
[TBL] [Abstract][Full Text] [Related]
25. In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.
Tani M; Tanimura H; Yamaue H; Iwahashi M; Tsunoda T; Tamai M; Noguchi K; Arii K
Eur J Clin Pharmacol; 1992; 42(6):623-7. PubMed ID: 1623902
[TBL] [Abstract][Full Text] [Related]
26. Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death.
Migliorati G; D'Adamio L; Coppi G; Nicoletti I; Riccardi C
Immunopharmacol Immunotoxicol; 1992; 14(4):737-48. PubMed ID: 1294620
[TBL] [Abstract][Full Text] [Related]
27. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
28. Natural killer (NK)-like cytotoxicity of murine intraepithelial lymphocytes in the small intestine (iIEL) and the effect of the serine proteases.
Kato Y; Yokochi T; Maeda K; Sasaki K; Kawamoto Y; Tsuji T; Miyama A
Microbiol Immunol; 1995; 39(4):291-4. PubMed ID: 7651243
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-alpha and interleukin-2 on natural killer cell function against tumor cell lines.
Alvarado CS; Findley HW; Chan WC; Hnath RS; Abdel-Mageed A; Pais RC; Kutner MH; Ragab AH
Cancer; 1989 Jan; 63(1):83-9. PubMed ID: 2783377
[TBL] [Abstract][Full Text] [Related]
30. Selective inhibition of leukotriene C4 synthesis and natural killer activity by ethacrynic acid.
Leung KH
Cell Immunol; 1988 Jul; 114(2):359-69. PubMed ID: 3390866
[TBL] [Abstract][Full Text] [Related]
31. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
32. Selective inhibition by alcohol and cortisol of natural killer cell activity of lymphocytes from cord blood.
Nair MP; Kronfol ZA; Greden JF; Chadha KC; Dumaswala UJ; Sweet AM; Schwartz SA
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1293-305. PubMed ID: 7863017
[TBL] [Abstract][Full Text] [Related]
33. Natural cytotoxicity of human blood monocytes: production of monocyte cytotoxic factors (MCF) during interaction with tumor cells.
Uchida A; Yanagawa E
Immunol Lett; 1984; 8(6):311-6. PubMed ID: 6597126
[TBL] [Abstract][Full Text] [Related]
34. Altered natural killer cell activity in childhood acute non-lymphoid leukaemia. Augmented natural killer cell activity and cells expressing the Leu 7 and Leu 11b (CD 16) markers in the bone marrow of children in remission.
Sørskaar D; Førre O; Tjønneland S; Lie SO
Scand J Immunol; 1988 Jul; 28(1):11-7. PubMed ID: 3261034
[TBL] [Abstract][Full Text] [Related]
35. Abnormal natural killer cytotoxicity in primary biliary cirrhosis: evidence for a functional deficiency of cytolytic effector cells.
James SP; Jones EA
Gastroenterology; 1985 Jul; 89(1):165-71. PubMed ID: 2408957
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of natural killer cell activity in mice treated with tobacco specific carcinogen NNK.
Goud SN; Kaplan AM
J Toxicol Environ Health A; 1999 Jan; 56(2):131-44. PubMed ID: 9972924
[TBL] [Abstract][Full Text] [Related]
37. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
Platsoucas CD
Eur J Immunol; 1984 Jun; 14(6):566-77. PubMed ID: 6610558
[TBL] [Abstract][Full Text] [Related]
38. An antiproliferative salicylaldoximato type copper(II) chelate as an enhancer of the cytotoxicity of murine spleen cells to tumor cells in vitro.
Elo H
Cancer Lett; 1987 Sep; 36(3):333-9. PubMed ID: 3652032
[TBL] [Abstract][Full Text] [Related]
39. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.
Mori S; Jewett A; Murakami-Mori K; Cavalcanti M; Bonavida B
Cancer Immunol Immunother; 1997 Jul; 44(5):282-90. PubMed ID: 9247563
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells.
Oshimi K; Oshimi Y; Akutsu M; Takei Y; Saito H; Okada M; Mizoguchi H
Blood; 1986 Oct; 68(4):938-48. PubMed ID: 3489494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
